Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 357.00
Bid: 357.00
Ask: 360.00
Change: -7.00 (-1.92%)
Spread: 3.00 (0.84%)
Open: 364.00
High: 369.00
Low: 357.00
Prev. Close: 364.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

6 Jul 2017 07:00

RNS Number : 2365K
Microgen PLC
06 July 2017
 

6 July 2017

 

MICROGEN plc ('Microgen' or 'Group')

 

TRADING UPDATE AND NOTICE OF RESULTS

 

 

Ahead of announcing Interim Results for the six months ended 30 June 2017 on 24 July 2017, Microgen (MCGN.L), a leading provider of business critical software and services, today issues the following update on trading for the financial year to date.

The Group has made excellent progress in the first half of 2017 resulting in a financial performance ahead of the Board's original expectations for the period whilst maintaining margins consistent with the prior year. The Group's two businesses are successfully executing their declared strategy with Aptitude Software delivering strong organic growth and Microgen Financial Systems successfully continuing on its transition towards a business focused on the Trust & Fund Administration ('T&FA') market.

A key highlight for the Group is the continued new business wins that have driven growth in Aptitude Software's recurring revenue base. Since 30 June 2016, the recurring revenue in Aptitude Software has increased 42% to £15.0 million as at 30 June 2017 (H1, 2016: £10.6 million and 31 December 2016: £12.6 million). There has also been exceptional growth in demand for Aptitude Software's implementation services in the first half of the year as a number of clients progress towards going live with the Aptitude Revenue Recognition Engine ('ARRE'). Upon completion of the half year the Board has reviewed the on-going demand for Aptitude Software's implementation services and, whilst clients' requirements continue to evolve, the Board is now confident that the exceptional level of demand experienced in the first six months of the year will continue throughout 2017, leading to a financial performance for the Group significantly ahead of the Board's expectations for the year. 

Opportunities for Aptitude's existing software and its new products provide the business with confidence for future years. Partners are becoming an increasingly important channel for new business, and as they provide a growing proportion of resources for new implementations, and as a number of the larger ARRE projects are completed, the exceptional level of demand for services experienced in 2017 is expected to moderate in 2018.

Microgen Financial Systems has maintained its focus on the T&FA market within the wealth management sector. The acquisition of Primacy Corporation in February 2017, a competitor in the T&FA market, represented the fifth acquisition since December 2014 and further strengthens the position of the business in this market. As a result of this focus T&FA revenues now represent approximately 60% of Microgen Financial Systems' H1 2017 revenue (H1, 2016: 51%), compared to 33% at the beginning of this transition in 2014.

 

Contacts

Ivan Martin, Chairman 020-7496-8100

Philip Wood, Chief Financial Officer

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUGMUPMGAA
Date   Source Headline
28th Jul 200912:05 pmRNSNotifiable Interests
24th Jul 200910:07 amRNSHolding(s) in Company
23rd Jul 200912:03 pmPRNHolding(s) in Company
23rd Jul 200911:17 amPRNPDMR Shareholding
23rd Jul 200910:52 amPRNHolding(s) in Company
21st Jul 20097:00 amRNSInterim Results
16th Jul 20094:16 pmPRNNotice of Results
14th Jul 20093:57 pmPRNBlocklisting - Interim Review
14th Jul 20093:50 pmPRNBlocklisting - Interim Review
7th Jul 20097:00 amRNSTrading Update
30th Apr 20092:43 pmRNSDirector/PDMR Shareholding
22nd Apr 20099:27 amPRNAGM Statement
22nd Apr 20097:00 amRNSInterim Management Statement
25th Mar 200911:41 amPRNAnnual Information Update
26th Feb 20091:58 pmPRNDirector Shareholding
25th Feb 200911:01 amPRNDirector Shareholding
24th Feb 20097:00 amRNSFinal Results
20th Feb 20099:33 amPRNNotice of Results
27th Jan 20091:52 pmPRNHolding(s) in Company
22nd Jan 20093:54 pmPRNBlocklisting - Interim Review
22nd Jan 20093:48 pmPRNHolding(s) in Company
16th Jan 20098:51 amPRNBlocklisting - Interim Review
17th Dec 20084:44 pmPRNHolding(s) in Company
3rd Dec 200811:34 amPRNHolding(s) in Company
2nd Dec 20084:20 pmPRNDirector/PDMR Shareholding
2nd Dec 20084:09 pmPRNDirector/PDMR Shareholding
2nd Dec 20089:47 amPRNHolding(s) in Company
27th Nov 20083:25 pmPRNHolding(s) in Company
27th Nov 20083:12 pmPRNTotal Voting Rights
21st Nov 20087:00 amRNSResult of Tender Offer
19th Nov 200811:28 amRNSResult of General Meeting
13th Nov 200812:50 pmRNSCorrection to Shareholder Circular
6th Nov 20089:47 amPRNHolding(s) in Company
31st Oct 20087:00 amRNSPosting of Shareholder Circular
14th Oct 20087:00 amRNSInterim Management Statement
4th Aug 20087:00 amPRNTotal Voting Rights
17th Jul 20087:00 amRNSInterim Results
15th Jul 20085:05 pmRNSNotice of Results
2nd Jul 20083:43 pmPRNBlocklisting - Interim Review
24th Jun 200812:35 pmRNSAdditional Listing
6th May 20086:04 pmPRNAnnual Information Update
2nd May 200810:15 amPRNDirector Shareholding
28th Apr 200810:48 amRNSStatement re Scisys plc
24th Apr 20089:26 amRNSRule 8.3- Microgen
24th Apr 20089:16 amRNSRule 8.3- Microgen
22nd Apr 20089:50 amRNSAGM Statement
22nd Apr 20087:00 amRNSInterim Management Statement
16th Apr 20089:13 amRNSOffer Update
16th Apr 20087:00 amRNSOffer Update
14th Apr 20089:42 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.